US2008022897A1PendingUtilityA1

Methods of forming a doped semiconductor thin film, doped semiconductor thin film structures, doped silane compositions, and methods of making such compositions

Assignee: ZURCHER FABIOPriority: Sep 24, 2004Filed: Oct 8, 2007Published: Jan 31, 2008
Est. expirySep 24, 2024(expired)· nominal 20-yr term from priority
H10P 14/3444H10P 14/3411H10P 14/265H10P 14/24H10P 14/3442
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for forming doped silane and/or semiconductor thin films, doped liquid phase silane compositions useful in such methods, and doped semiconductor thin films and structures. The composition is generally liquid at ambient temperatures and includes a Group IVA atom source and a dopant source. By irradiating a doped liquid silane during at least part of its deposition, a thin, substantially uniform doped oligomerized/polymerized silane film may be formed on a substrate. Such irradiation is believed to convert the doped silane film into a relatively high-molecular weight species with relatively high viscosity and relatively low volatility, typically by cross-linking, isomerization, oligomerization and/or polymerization. A film formed by the irradiation of doped liquid silanes can later be converted (generally by heating and annealing/recrystallization) into a doped, hydrogenated, amorphous silicon film or a doped, at least partially polycrystalline silicon film suitable for electronic devices. Thus, the present invention enables use of high throughput, low cost equipment and techniques for making doped semiconductor films of commercial quality and quantity from doped “liquid silicon.”

Claims

exact text as granted — not AI-modified
1 . A composition, comprising: 
 a) a compound of the formula A x H y , where each A is independently Si or Ge, x is from 3 to 20, and y is from x to (2x+2); and    b) at least one dopant of the formula B a R 1   b  and/or (R 2   3 A) r A c (BR 1   2 ) s , where a is from 1 to 20; b is an integer corresponding to the number of binding sites available on the a instances of B, each R 1  is independently H, alkyl, aralkyl or AR 2   3 , and at least one of the b instances of R 1  is alkyl, aralkyl or AR 2   3 ; R 2  is hydrogen, alkyl, aryl, aralkyl or A y H 2y+1 ; c is 1 to 4, r+s=2c+2, and s≧1.    
   
   
       2 . The composition of  claim 1 , wherein said compound has the formula (AH x ) k , where k is from 3 to 12, and each of the k instances of x is 1 or 2.  
   
   
       3 . The composition of  claim 2 , wherein said compound is monocyclic, k is from 4 to 8, and x is 2.  
   
   
       4 . The composition of  claim 1 , wherein A is Si.  
   
   
       5 . The composition of  claim 1 , wherein said dopant has the formula B a′ R 1   b′ , where a′ is 1 or 2; b′ is 3a′, at least a′ instances of R′ are C 1 -C 6  alkyl, and the remainder of the b′ instances of R 1  are independently H, C 1 -C 6  alkyl, C 6 -C 10  aryl, C 7 -C 10  aralkyl or AR 2   3 , where R 2  is hydrogen or A y H 2y+1  (1≦y≦4).  
   
   
       6 . The composition of  claim 5 , wherein R 1  is C 1 -C 6  alkyl.  
   
   
       7 . The composition of  claim 6 , wherein R 1  is methyl, ethyl, propyl or butyl.  
   
   
       8 . The composition of  claim 6 , wherein A is Si.  
   
   
       9 . The composition of  claim 1 , wherein c is 1 and R 1  is H, C 1 -C 6  alkyl, C 6 -C 10  aryl, or AR 2   3 , where R 2  is hydrogen or A y H 2y+1  (1≦y≦4).  
   
   
       10 . The composition of  claim 9 , wherein R 1  is H, t-butyl, phenyl, or AH 3 .  
   
   
       11 . The composition of  claim 1 , wherein from 0.00001 to 50 vol % of said composition consists essentially of said dopant and from 0.5 to 99.999 vol % of said composition consists essentially of said compound.  
   
   
       12 . The composition of  claim 11 , further comprising a solvent in which said compound and said dopant are soluble.  
   
   
       13 . The composition of  claim 12 , wherein said solvent is selected from the group consisting of alkanes, substituted alkanes, cycloalkanes, substituted cycloalkanes, arenes, substituted arenes, and (cyclic) siloxanes.  
   
   
       14 . The composition of  claim 13 , wherein said solvent is selected from the group consisting of C 5 -C 10  monocycloalkanes; C 3 -C 8  monocycloalkanes substituted with from 1 to 2n C 1 -C 4  alkyl or halogen substituents or from 1 to n C 1 -C 4  alkoxy substituents; C 10 -C 14  polycycloalkanes; siloxanes of the formula (R 3   3 Si)(OSiR 3   2 ) p (OSiR 3   3 ), where p is from 0 to 4, and each R 3  is independently H, C 1 -C 6  alkyl, benzyl or phenyl substituted with from 0 to 3 C 1 -C 4  alkyl groups; cyclosiloxanes of the formula (SiR 4   2 O) q , where q is from 2 to 6, and each R 4  is independently H, C 1 -C 6  alkyl, benzyl or phenyl substituted with from 0 to 3 C 1 -C 4  alkyl groups; and C 3 -C 8  fluoroalkanes substituted with from 1 to (2n+2) fluorine atoms, where n is the number of carbon atoms in the selected solvent.  
   
   
       15 . The composition of  claim 14 , wherein said solvent is a C 6 -C 10  monocycloalkane or a C 10 -C 14  polycycloalkane.  
   
   
       16 . The composition of  claim 11 , wherein A is Si.  
   
   
       17 . The composition of  claim 12 , wherein from 0.5 to 50 vol % of said composition consists essentially of said compound.  
   
   
       18 . The composition of  claim 17 , wherein from 1 to 35 vol % of said composition consists essentially of said compound.  
   
   
       19 . The composition of  claim 18 , wherein from about 5 to 25 vol % of said composition consists essentially of said compound.  
   
   
       20 . The composition of  claim 12 , wherein from about 1 to about 25 wt. % of said composition consists essentially of said compound, and dopant is present in an amount providing from about 0.0001 to about 10 at. % of B atoms with respect to A atoms in said compound.

Join the waitlist — get patent alerts

Track US2008022897A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.